The health and safety of the people working in University Research Park is of the upmost priority. As we collectively monitor and react to the news of the spread of the novel coronavirus (COVID-19), we want to make you aware of steps University Research Park...
devTOX quickPredict (devTOXqP) screening platform developed by Stemina Biomarker Discovery, Inc. demonstrated the platform’s ability to predict developmental toxicity in humans with high accuracy using a cell-based test....
Forward Biolabs opened in February 2019 at 504 South Rosa Road after starting in temporary space the previous September. The facility has one main goal, said CEO Jessica Martin Eckerly. “The whole purpose is to minimize the hurdles to starting a biotech company in Wisconsin,”...
JangoBio, Fitchburg company based on research by a UW-Madison gerontologist, has created three-dimensional tissue clusters derived from stem cells that can produce ovarian and testicular hormones. The development could help regenerate and replace hormone-producing tissues and reverse the natural decline of sex hormones from aging....
Stemina Biomarker Discovery, Inc., today announced study results showing the high performance of the company’s Cardio quickPredict test in identifying cardiotoxic effects for a large number of well-characterized drugs....
Dianomi previously licensed its core technology, the mineral coated microparticles, from WARF, UW-Madison's tech-transfer arm. The new license expands the technology's use to nucleic acid therapy — using DNA or RNA, or related compounds, to modify or enhance the expression of desired genes....
Cancer diagnostics company Exact Sciences Corp. has more than doubled the capital investment and job creation numbers it proposed under an agreement with the Wisconsin Economic Development Corp., according to documents obtained by the Milwaukee Business Journal per a public records request....
Exact Sciences brought in about $230 million in screening revenue during the fourth quarter of last year, according to the company’s latest preliminary financial report....
A $267 million stock offering last week by Arrowhead Pharmaceuticals, which has its main employment base in Madison, could help the company bring experimental drugs to market and lead to the purchase of other businesses....
Exact Sciences announced Dr. David Ahlquist, co-inventor of Cologuard® has been named a Fellow of the National Academy of Inventors (NAI)....